Učitavanje...
Gene Therapy for Immune Tolerance Induction in Hemophilia with Inhibitors
The development of inhibitors, neutralizing alloantibodies to Factor VIII (FVIII) or Factor IX (FIX), is the most significant complication of protein replacement therapy for patients with hemophilia and is associated with increased mortality as well as substantial physical, psychosocial, and financi...
Spremljeno u:
| Izdano u: | J Thromb Haemost |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4907803/ https://ncbi.nlm.nih.gov/pubmed/27061380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.13331 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|